CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Service...

FDA Recall #D-0279-2023 — Class II — December 27, 2022

Recall #D-0279-2023 Date: December 27, 2022 Classification: Class II Status: Terminated

Product Description

CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

Reason for Recall

Lack of sterility assurance

Recalling Firm

Sentara Infusion Services — Chesapeake, VA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

8 syringes

Distribution

Dispensed to Patients Nationwide.

Code Information

Beyond Use Date: December 29-31, 2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated